Lantz Financial’s Johnson & Johnson JNJ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $3.27M | Sell |
12,860
-223
| -2% | -$52K | 0.6% | 40 |
|
|
2026
Q1 | $3.2M | Sell |
13,083
-1,346
| -9% | -$314K | 0.66% | 31 |
|
|
2025
Q4 | $2.99M | Sell |
14,429
-814
| -5% | -$161K | 0.63% | 34 |
|
|
2025
Q3 | $2.83M | Buy |
15,243
+3,351
| +28% | +$574K | 0.63% | 38 |
|
|
2025
Q2 | $1.82M | Sell |
11,892
-82
| -0.7% | -$12.6K | 0.45% | 65 |
|
|
2025
Q1 | $1.99M | Buy |
11,974
+377
| +3% | +$59K | 0.54% | 54 |
|
|
2024
Q4 | $1.68M | Buy |
11,597
+273
| +2% | +$42.3K | 0.45% | 64 |
|
|
2024
Q3 | $1.84M | Buy |
11,324
+1,223
| +12% | +$195K | 0.5% | 62 |
|
|
2024
Q2 | $1.48M | Sell |
10,101
-135
| -1% | -$20.1K | 0.46% | 66 |
|
|
2024
Q1 | $1.62M | Sell |
10,236
-102
| -1% | -$16.2K | 0.52% | 59 |
|
|
2023
Q4 | $1.62M | Buy |
10,338
+395
| +4% | +$60.6K | 0.59% | 50 |
|
|
2023
Q3 | $1.55M | Buy |
9,943
+43
| +0.4% | +$7.09K | 0.62% | 46 |
|
|
2023
Q2 | $1.64M | Sell |
9,900
-101
| -1% | -$16.3K | 0.64% | 46 |
|
|
2023
Q1 | $1.55M | Sell |
10,001
-306
| -3% | -$49.4K | 0.64% | 48 |
|
|
2022
Q4 | $1.82M | Buy |
10,307
+125
| +1% | +$21.6K | 0.83% | 32 |
|
|
2022
Q3 | $1.66M | Sell |
10,182
-50
| -0.5% | -$8.46K | 0.87% | 28 |
|
|
2022
Q2 | $1.82M | Buy |
10,232
+18
| +0.2% | +$3.21K | 0.82% | 26 |
|
|
2022
Q1 | $1.81M | Buy |
10,214
+35
| +0.3% | +$5.96K | 0.74% | 33 |
|
|
2021
Q4 | $1.74M | Sell |
10,179
-157
| -2% | -$25.7K | 0.8% | 34 |
|
|
2021
Q3 | $1.67M | Buy |
10,336
+285
| +3% | +$48.6K | 0.86% | 30 |
|
|
2021
Q2 | $1.66M | Buy |
10,051
+150
| +2% | +$24.8K | 0.85% | 31 |
|
|
2021
Q1 | $1.63M | Buy |
9,901
+68
| +0.7% | +$11K | 0.93% | 30 |
|
|
2020
Q4 | $1.55M | Buy |
9,833
+411
| +4% | +$60.7K | 0.97% | 26 |
|
|
2020
Q3 | $1.4M | Buy |
9,422
+337
| +4% | +$49.9K | 0.94% | 32 |
|
|
2020
Q2 | $1.28M | Buy |
9,085
+430
| +5% | +$62.7K | 0.92% | 33 |
|
|
2020
Q1 | $1.14M | Buy |
8,655
+1,068
| +14% | +$152K | 0.89% | 38 |
|
|
2019
Q4 | $1.11M | Sell |
7,587
-221
| -3% | -$30K | 0.66% | 53 |
|
|
2019
Q3 | $1.03M | Sell |
7,808
-230
| -3% | -$30.3K | 0.7% | 53 |
|
|
2019
Q2 | $1.13M | Sell |
8,038
-771
| -9% | -$107K | 0.76% | 46 |
|
|
2019
Q1 | $1.23M | Buy |
+8,809
| New | +$1.18M | 0.89% | 40 |
|
Other funds holding JNJ
Lantz Financial's JNJ Position: Q2 2026 in Review
Lantz Financial reduced its Johnson & Johnson (JNJ) stake by 1.7% in Q2 2026, selling an estimated $52K and leaving 12,860 shares worth $3.27M. The position accounts for 0.6% of the portfolio, ranked #40.
Lantz Financial first reported a position in JNJ in Q1 2019 and has held it in 30 quarters since. 4,677 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.
- Lantz Financial held 12,860 shares of Johnson & Johnson worth $3.27M as of Q2 2026.
- Lantz Financial sold 223 Johnson & Johnson shares in Q2 2026, an estimated $52K.
- Johnson & Johnson made up 0.6% of Lantz Financial's portfolio in Q2 2026, its #40 holding.
- Lantz Financial first reported a position in Johnson & Johnson in Q1 2019 and has held it in 30 quarters since.
- 4,677 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.
Based on Lantz Financial's 13F filing for Q2 2026, filed 9 Jul 2026.